Mechanical Circulatory Support in Cardiogenic Shock due to Structural Heart Disease

Authors

Pedro Villablanca, Henry Ford HealthFollow
Paul Nona, Henry Ford HealthFollow
Alejandro Lemor, Henry Ford HealthFollow
Mohammed Qintar, Henry Ford HealthFollow
Brian P. O'Neill, Henry Ford HealthFollow
James Lee, Henry Ford HealthFollow
Tiberio Frisoli, Henry Ford HealthFollow
Dee Dee Wang, Henry Ford HealthFollow
Marvin H. Eng, Henry Ford HealthFollow
William W. O'Neill, Henry Ford HealthFollow

Recommended Citation

Villablanca P, Nona P, Lemor A, Qintar M, O'Neill B, Lee J, Frisoli T, Wang DD, Eng MH, and O'Neill WW. Mechanical Circulatory Support in Cardiogenic Shock due to Structural Heart Disease. Interv Cardiol Clin 2021; 10(2):221-234.

Document Type

Article

Publication Date

4-1-2021

Publication Title

Interv Cardiol Clin

Abstract

Despite advances in cardiovascular care, managing cardiogenic shock caused by structural heart disease is challenging. Patients with cardiogenic shock are critically ill upon presentation and require early disease recognition and rapid escalation of care. Temporary mechanical circulatory support provides a higher level of care than current medical therapies such as vasopressors and inotropes. This review article focuses on the role of hemodynamic monitoring, mechanical circulatory support, and device selection in patients who present with cardiogenic shock due to structural heart disease. Early initiation of appropriate mechanical circulatory support may reduce morbidity and mortality.

PubMed ID

33745671

Volume

10

Issue

2

First Page

221

Last Page

234